Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Urothelial carcinoma

  • Open Access
    Transcriptome-based Deep Learning Model for Predicting Gemcitabine and Cisplatin Chemotherapy Response in Urothelial Carcinoma: Development and External Validation
    JUWON KANG, HYUN JUNG LEE, SANG-BO OH, JONG KIL NAM, TAE UN KIM, HWASEONG RYU, YONG KAN KI, JIHOON KANG, YI RANG KIM, JEONG HOON LEE, JUNJEONG CHOI, YUN JEONG HONG and KWONOH PARK
    Cancer Genomics & Proteomics May 2026, 23 (3) 546-557; DOI: https://doi.org/10.21873/cgp.20589
  • Open Access
    Pioglitazone Suppresses Urothelial Tumorigenesis In Vitro: A Potential Chemopreventive Agent
    NGUYEN THU QUYNH, YUJIRO NAGATA, TAKUO MATSUKAWA, EIJI KASHIWAGI and NAOHIRO FUJIMOTO
    Cancer Genomics & Proteomics September 2025, 22 (5) 750-759; DOI: https://doi.org/10.21873/cgp.20534
  • Open Access
    Melatonin Inhibits Chemical Carcinogen-mediated Malignant Transformation of Urothelial Cells: In Vitro Evidence
    YUJIRO NAGATA, NGUYEN THU QUYNH, HISAMI AONO, KENICHI HARADA, HIROSHI MIYAMOTO and NAOHIRO FUJIMOTO
    Cancer Genomics & Proteomics July 2024, 21 (4) 388-394; DOI: https://doi.org/10.21873/cgp.20456
  • Open Access
    Target Genes of Recurrent Chromosomal Amplification and Deletion in Urothelial Carcinoma
    MERLIN WEILANDT, ANNEMARIE KOCH, HARALD RIEDER, RENÉ DEENEN, HOLGER SCHWENDER, GÜNTER NIEGISCH and WOLFGANG A. SCHULZ
    Cancer Genomics & Proteomics May 2014, 11 (3) 141-153;
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire